CMGUB24000 // A031701 // GUERCIO
Basic Study Information
Purpose:
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work
in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy,
such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the
growth of tumor cells, either by killing the cells, by stopping them from dividing,
or by stopping them from spreading.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Brendan Guercio
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search